Company / Assets per Share
Arcadia Biosciences, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$4.80
FY2025
5-year range
$3.27 / $52.15
FY2021-FY2025
Trend
-54.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Assets per Share has declined for 3 consecutive years, from $52.15 in FY2022 to $4.80 in FY2025.
Based on SEC 10-K filings.
4.80 in FY2025 with a 5-year CAGR of -2.6%.
Declined from $31.98 to $4.80 over the past 2 years.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -54.9%
- 5-Year CAGR
- -2.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- Arcadia Biosciences, Inc.'s assets per share has declined for 3 consecutive years.
- In FY2025, assets per share decreased 54.4% year-over-year.
- Peak assets per share was recorded in FY2022.
- Lowest assets per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 7.60 (safe zone, above 2.9 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $4.80 | -54.4% |
| FY2024 | $10.52 | -67.1% |
| FY2023 | $31.98 | -38.7% |
| FY2022 | $52.15 | +1497.2% |
| FY2021 | $3.27 | -40.4% |
| FY2020 | $5.48 | -19.7% |
| FY2019 | $6.82 | -39.4% |
| FY2018 | $11.26 | +51.1% |
| FY2017 | $7.45 | +481.8% |
| FY2016 | $1.28 | -96.4% |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026